If you spend a few minutes going through the headlines of OTC-BB and Pink Sheet listed stocks, it becomes evident that investors in that space are on their own.  But sometimes there are a few...
These are the top analyst upgrades we are seeing from Wall Street early this Tuesday morning: Force Protection (NASDAQ: FRPT) Raised to Buy at Collins Stewart. Infosys (NASDAQ: INFY) Started as...
many investors objected to the 2011 pay package of JP Morgan (NYSE: JPM) CEO Jamie Dimon. He made $23 million, which was more than any other bank chief executive. Dimon also was criticized for his...
Sierra Pacific Resources (NYSE:SRP) announced today that its two Nevada-based utility subsidiaries, Nevada Power Company and Sierra Pacific Power Company, have issued a Request for Proposals for...
We have provided links through on our day trading alerts page this morning.  Each stock is seeing active trading right before the open and brief explanations and analysis are offered at...
These are not the only analyst calls impacting individual share prices, but these are the ones that 247WallSt.com is focusing on: Charles River (NYSE: CRL) downgraded from Buy to Neutral at UBS....
We have some major changes announced by S&P for its three key indexes.  Changes are in the S&P 500 Index, S&P Mid-Cap 400 Index, and in the S&P SMall Cap 600 Index.Marathon Petroleum Corporation...
Markets opened up a bit this morning, but by 10:00 a.m. equities had turned back down, with the DJIA sliding down nearly -200 points before rallying back to its opening mark in the early afternoon....
Below is a summary of many of the top headlines and news bits from individual stocks affecting share prices in pre-market trading this Wednesday: Actuant (ATU) $0.52 EPS vs $0.48 estimate. ADC...
Sarepta shares jumped on Friday after the firm announced an update from its Duchenne muscular dystrophy trial.
Source: thinkstockHere are today’s five biggest gaining stocks at closing:Mattersight Corp. (NASDAQ: MATR) is up 29.4% at $2.33.Comstock Holding Companies Inc. (NASDAQ: CHCI) is up 19% at...
Sarepta Therapeutics Inc. (NASDAQ: SRPT) has seen more than its fair share of volatility in the market of late. Now shares are surging after it has reached a compromise with the U.S. Food and Drug...
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares saw a handy gain on Wednesday following an analyst upgrade from Janney Montgomery Scott.
Shares of Summit Therapeutics more than doubled on Tuesday after it was announced that it would be entering into a licensing deal with Sarepta Therapeutics.
One of Cathie Wood's Ark Invest funds sold almost 178,000 shares of Roche on August 19.